Gregory Neel, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 410 Celebration Pl Ste 305, Celebration, FL 34747 Phone: 407-303-4120 Fax: 407-303-4124 |
Dr. Bruce Harwood Haughey, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 410 Celebration Pl Ste 305, Celebration, FL 34747 Phone: 407-303-4120 Fax: 407-303-4124 |
Dr. Uthman Abdulrahman Alamoudi, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 410 Celebration Pl Ste 305, Celebration, FL 34747 Phone: 407-303-4120 Fax: 407-303-4124 |
Michael D. Seidman, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 410 Celebration Pl Ste 305, Celebration, FL 34747 Phone: 407-303-4120 Fax: 407-303-4124 |
Dr. Andrea Costantino, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 410 Celebration Pl Ste 305, Celebration, FL 34747 Phone: 689-280-6805 |
Dr. Fawaz Mohammedmakki Hassan Makki, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 410 Celebration Pl Ste 305, Celebration, FL 34747 Phone: 407-303-4120 Fax: 407-303-4124 |
Dr. Mathew Biskup, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 410 Celebration Pl Ste 100, Celebration, FL 34747 Phone: 321-939-3000 Fax: 321-939-3001 |
Luis Pablo Roldan, Otolaryngology Medicare: Medicare Enrolled Practice Location: 410 Celebration Pl Ste 100, Celebration, FL 34747 Phone: 321-939-3000 Fax: 321-939-3001 |
Jeffery S Magnuson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 410 Celebration Pl, Suite 305, Celebration, FL 34747 Phone: 407-303-4120 Fax: 407-303-4124 |
News Archive
IsoRay, Inc. announced today that starting on August 12, 2009, Dr. Bhupesh Parashar from the Department of Radiation Oncology, and Dr. Nasser Altorki of the Department of Cardiothoracic Surgery at Weill Cornell Medical Center performed the world's first Cesium-131 lung implants.
Houston Methodist received FDA approval Saturday to become the first academic medical center in the nation to transfuse donated plasma from a recovered COVID-19 patient into a critically ill patient.
Researchers from the University of Copenhagen are the first in the world to develop a secure way of measuring the important protein apo-M. This could prove relevant for research into diseases such as diabetes, arteriosclerosis and sclerosis.
Revance Therapeutics, Inc. today announced the closing of a $45 million financing led by Essex Woodlands Health Ventures and new investor, NovaQuest Capital.
› Verified 4 days ago